0001104659-20-063184.txt : 20200518
0001104659-20-063184.hdr.sgml : 20200518
20200518161727
ACCESSION NUMBER: 0001104659-20-063184
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200514
FILED AS OF DATE: 20200518
DATE AS OF CHANGE: 20200518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Erlander Mark
CENTRAL INDEX KEY: 0001651537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35558
FILM NUMBER: 20889728
MAIL ADDRESS:
STREET 1: C/O TROVAGENE, INC.
STREET 2: 11055 FLINTKOTE AVENUE, SUITE A
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiff Oncology, Inc.
CENTRAL INDEX KEY: 0001213037
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 272004382
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-952-7570
MAIL ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Trovagene, Inc.
DATE OF NAME CHANGE: 20130304
FORMER COMPANY:
FORMER CONFORMED NAME: TrovaGene Inc.
DATE OF NAME CHANGE: 20110830
FORMER COMPANY:
FORMER CONFORMED NAME: XENOMICS INC
DATE OF NAME CHANGE: 20040719
4
1
a4.xml
4
X0306
4
2020-05-14
0
0001213037
Cardiff Oncology, Inc.
CRDF
0001651537
Erlander Mark
C/O CARDIFF ONCOLOGY, INC.
11055 FLINTKOTE
SAN DIEGO
CA
92121
0
1
0
0
Chief Executive Officer
Common Stock
2020-05-14
4
P
0
6993
1.43
A
13369
D
/s/ Mark Erlander
2020-05-18